SCHEMBL9259744

SCHEMBL9259744

CC(c1cccc(C(C)N(C(=O)Nc2ccc(F)cc2F)C2CCCCC2)c1)N(C(=O)Nc1ccc(F)cc1F)C1CCCCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.51
▸ CYP1A2 P05177 2/20 0.51
▸ CYP3A4 P08684 2/20 0.51
▸ CYP2C9 P11712 2/20 0.51
▸ CYP2C19 P33261 2/20 0.51
▸ POLB P06746 3/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ HTT P42858 2/20 0.49
▸ MAPT P10636 4/20 0.46
▸ TSHR P16473 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ PPARG P37231 1/20 0.46
▸ PPARD Q03181 1/20 0.46
▸ PPARA Q07869 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ RECQL P46063 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9260548 0.81 HTT (0.51) GAAPOLBNPC1RAB9AHTT
SCHEMBL10447080 0.80 HTT (0.49) GAAPOLBNPC1RAB9AHTT
SCHEMBL27264919 0.80 HTT (0.64) GAAPOLBNPC1RAB9AHTT
SCHEMBL10446934 0.76 HTT (0.47) POLBNPC1RAB9AHTTMAPT
SCHEMBL23718871 0.74 MAPT (0.48) CYP1A2CYP3A4CYP2C9CYP2C19POLB
SCHEMBL23200019 0.74 MAPT (0.48) CYP1A2CYP3A4CYP2C9CYP2C19POLB
SCHEMBL9261512 0.74 PPARG (0.55) POLBNPC1RAB9AHTTMAPT
SCHEMBL9257865 0.74 PPARG (0.55) POLBNPC1RAB9AHTTMAPT
SCHEMBL9263100 0.74 PPARG (0.55) POLBNPC1RAB9AHTTMAPT
SCHEMBL9260752 0.74 PPARG (0.55) POLBNPC1RAB9AHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5384425-A Diurea derivatives useful as medicaments and processes for the preparation thereof YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1995-01-24 — — US disclosed
EP-0325397-B1 DIUREA DERIVATIVES USEFUL AS MEDICAMENTS AND PROCESSES FOR THE PREPARATION THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1993-08-18 — — EP disclosed
US-5166429-A Enzyme inhibitors of acylcoenzyme A cholesterol transferase as anticholesterol agents or antideposit agents YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1992-11-24 — — US disclosed
US-5091419-A Anticholesterol agent YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1992-02-25 — — US disclosed
Send feedback